Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03379428 |
| Title | Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | US Oncology Research |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| 10 sites incl TX, WA, VA, and NV | Dallas | Texas | 75246 | United States | Details |